877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Nicotinic agonists, Isoxazoles

Categories

Cholinergics (2)
Cyclic compounds (2)
Drugs acting on the nervous system (2)
Five-membered rings (2)
Neurotoxins (2)
Parasympathomimetics (2)
Psychoactive drugs (2)
Psychoanaleptics (2)
Stimulants (2)
Nervous system drug (1)
Nootropics (1)
Pyrrolidines (1)
Ureas (1)

Suppliers

Matrix Scientific (1)
Sigma Aldrich (1)

Abt-418 (147402-53-7)  
ABT-418 is a drug developed by Abbott, that has nootropic, neuroprotective and anxiolytic effects, and has been researched for treatment of both Alzheimer's disease and ADHD. It acts as an agonist at neural nicotinic acetylcholine receptors, subtype-selective binding with high affinity to the α4β2, α7/5-HT3, and α2β2 nicotinic acetylcholine receptors but not the α3β4 subtype familiar to nicotine. ABT-418 was reasonably effective for both applications and fairly well tolerated, but produced some side effects, principally nausea, and it is unclear whether ABT-418 itself will proceed to clinical development or if another similar drug will be used instead.
501925-31-1 (501925-31-1)  
PNU-120596 is a drug that acts as a potent and selective positive allosteric modulator for the α7 subtype of neural nicotinic acetylcholine receptors. It is used in scientific research into cholinergic regulation of dopamine and glutamate release in the brain.
Related searches
Nicotinic agonists
Isoxazoles